SBIO ALPS Medical Breakthroughs ETF $41.39
As of 1:00:00 AM EDT | 12/06/19 | Market Closed
Volume Monthly Avg. Volume 37,205
Quarterly Avg. Volume 32,903
SBIO Fund Description The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion. It seeks to replicate the performance of the Poliwogg Medical Breakthroughs Index, by investing in the stocks of companies as per their weightings in the index.
SBIO Summary Tracks This Index ALPS Medical Breakthroughs ETF
Asset Class Portfolio-Multi Asset
Asset Class Size Healthcare
SBIO Holdings Top 10 Holdings ACADIA Pharmaceuticals Inc. (
ACAD )
5.26%
United Therapeutics Corp. (
UTHR )
4.3%
Mirati Therapeutics Inc. (
MRTX )
3.61%
Global Blood Therapeutics Inc. (
GBT )
3.55%
Halozyme Therapeutics Inc. (
HALO )
2.95%
Total SBIO Holdings Total Holdings: 79 ACADIA Pharmaceuticals Inc. (
ACAD )
5.26%
United Therapeutics Corp. (
UTHR )
4.3%
Mirati Therapeutics Inc. (
MRTX )
3.61%
Global Blood Therapeutics Inc. (
GBT )
3.55%
Halozyme Therapeutics Inc. (
HALO )
2.95%
Emergent BioSolutions Inc. (
EBS )
2.78%
PTC Therapeutics Inc. (
PTCT )
2.71%
Acceleron Pharma Inc. (
XLRN )
2.47%
Arena Pharmaceuticals Inc. (
ARNA )
2.45%
Deciphera Pharmaceuticals Inc. (
DCPH )
2.44%
Ra Pharmaceuticals Inc. (
RARX )
2.32%
Agios Pharmaceuticals Inc. (
AGIO )
2.31%
Ligand Pharmaceuticals Inc. (
LGND )
2.21%
Eidos Therapeutics Inc. (
EIDX )
2.14%
Akcea Therapeutics Inc. (
AKCA )
1.84%
Apellis Pharmaceuticals Inc. (
APLS )
1.8%
Madrigal Pharmaceuticals Inc. (
MDGL )
1.69%
Dicerna Pharmaceuticals Inc. (
DRNA )
1.62%
Enanta Pharmaceuticals Inc. (
ENTA )
1.26%
Cara Therapeutics Inc. (
CARA )
1.18%
Constellation Pharmaceuticals Inc. (
CNST )
1.08%
Orchard Therapeutics PLC (
ORTX )
1.04%
Y-mAbs Therapeutics Inc. (
YMAB )
1.03%
Krystal Biotech Inc. (
KRYS )
0.99%
Fate Therapeutics Inc. (
FATE )
0.99%
G1 Therapeutics Inc. (
GTHX )
0.93%
Achillion Pharmaceuticals Inc. (
ACHN )
0.91%
Anika Therapeutics Inc. (
ANIK )
0.84%
Rhythm Pharmaceuticals Inc. (
RYTM )
0.8%
Principia Biopharma Inc. (
PRNB )
0.78%
Kura Oncology Inc. (
KURA )
0.72%
MeiraGTx Holdings PLC (
BFYQFJ )
0.69%
UroGen Pharma Ltd. (
URGN )
0.65%
Magenta Therapeutics Inc. (
MGTA )
0.57%
Voyager Therapeutics Inc. (
VYGR )
0.55%
Viking Therapeutics Inc. (
VKTX )
0.55%
Progenics Pharmaceuticals Inc. (
PGNX )
0.47%
Crinetics Pharmaceuticals Inc. (
CRNX )
0.47%
Rigel Pharmaceuticals Inc. (
RIGL )
0.41%
Assembly Biosciences Inc. (
ASMB )
0.38%
AMAG Pharmaceuticals Inc. (
AMAG )
0.38%
Puma Biotechnology Inc. (
PBYI )
0.37%
PDL BioPharma Inc. (
PDLI )
0.36%
ProQR Therapeutics NV (
PRQR )
0.34%
Scholar Rock Holding Corp. (
SRRK )
0.33%
Corbus Pharmaceuticals Holdings Inc. (
CRBP )
0.31%
Xenon Pharmaceuticals Inc. (
XENE )
0.25%
Minerva Neurosciences Inc. (
NERV )
0.25%
Albireo Pharma Inc. (
ALBO )
0.25%
GlycoMimetics Inc. (
GLYC )
0.22%
Kiniksa Pharmaceuticals Ltd. (
KNSA )
0.19%
Concert Pharmaceuticals Inc. (
CNCE )
0.17%
Marker Therapeutics Inc. (
MRKR )
0.14%
PhaseBio Pharmaceuticals Inc. (
PHAS )
0.1%
Acorda Therapeutics Inc. (
ACOR )
0.1%
Aduro Biotech Inc. (
ADRO )
0.09%
ALPS Medical Breakthroughs ETF (
SBIO )
0%
SBIO Dividends Annual Dividend Yield 1.92
© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions .
Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer .